Skip to content

Prospective Femoral Versus Femoral and Sciatic Nerve Block for Anterior Cruciate Ligament (ACL) Reconstruction

The Addition of a Preoperative Sciatic Nerve Block to a Femoral Nerve Block for Ambulatory Arthroscopic ACL Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01447277
Enrollment
68
Registered
2011-10-06
Start date
2011-10-31
Completion date
2013-06-30
Last updated
2020-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Tear

Keywords

ACL reconstruction, Femoral Block, Sciatic Block

Brief summary

The investigators propose that a preoperative femoral and sciatic blocks vs a femoral block only, prior to ambulatory anterior cruciate ligament (ACL) reconstruction will lead to a decrease in opiate consumption, pain scores, and post-anesthesia care unit (PACU) length of stay. The investigators are prospectively randomizing patients to either a femoral or a fem/sciatic block and monitor outcomes.

Detailed description

Although femoral nerve blocks improve analgesia after anterior cruciate ligament (ACL) reconstruction, patients often complain of posterior knee pain, which can be treated with a sciatic nerve block. In a prospective randomized study, we compare preoperative femoral nerve block to a combined femoral and sciatic block in patients undergoing ambulatory ACL reconstruction. We hypothesize that the combined femoral/sciatic nerve block patients would have improved analgesia, fewer opioid-related side effects, and shorter PACU length of stay and improved patient satisfaction.

Interventions

PROCEDURESciatic Block

Performing a sciatic block in addition to a femoral block preoperatively

PROCEDUREFemoral Block only

Performing a preoperative sciatic nerve block only

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 and over * ASA status I-II * Scheduled for ambulatory Arthroscopic ACL Surgery

Exclusion criteria

* Allergy to Local anesthetics or opiates used in the study * Contraindications for regional anesthesia * coagulopathy, anticoagulation, Thrombocytopenia * infection at site of injection * Chronic pain and high preoperative opiate requirements * High risk for PONV

Design outcomes

Primary

MeasureTime frame
Pain ScoresPACU and POD1, 2 and 3.

Secondary

MeasureTime frame
Length of stayDuration of stay in the recovery room
Opiate consumptionDuring surgery, recovery room and for 3 days after discharge
PONVDuring the recovery room stay and after discharge from surgery center for up to 3 days.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026